Vancouver Prostate Centre
10
1
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.0%
1 terminated/withdrawn out of 10 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Role: collaborator
A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
Role: collaborator
PC 360 Survivorship
Role: collaborator
Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer
Role: lead
Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance
Role: collaborator
Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT
Role: collaborator
Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT
Role: lead
Intimacy and Mindfulness Post-Prostate Cancer Treatment
Role: lead
Living With Prostate Cancer (LPC)
Role: lead
Comparing Rectus Sheath Catheter to Epidural Post Cystectomy
Role: collaborator
All 10 trials loaded